374 related articles for article (PubMed ID: 21702008)
21. Altered profile of circulating microparticles in rheumatoid arthritis patients.
Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Carro-Esteban SR; Ballina-García FJ; Suárez A
Clin Sci (Lond); 2015 Apr; 128(7):437-48. PubMed ID: 25369551
[TBL] [Abstract][Full Text] [Related]
22. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
23. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.
Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J
Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137
[TBL] [Abstract][Full Text] [Related]
24. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
25. Microparticles from Endothelial Cells and Immune Cells in Patients with Takayasu Arteritis.
Cheng X; Dang A; Lv N; Zhao T
J Atheroscler Thromb; 2019 Jun; 26(6):547-558. PubMed ID: 30555130
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
[TBL] [Abstract][Full Text] [Related]
27. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension.
Amabile N; Heiss C; Real WM; Minasi P; McGlothlin D; Rame EJ; Grossman W; De Marco T; Yeghiazarians Y
Am J Respir Crit Care Med; 2008 Jun; 177(11):1268-75. PubMed ID: 18310479
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic role of endothelial microparticles in vasculitis.
Erdbruegger U; Grossheim M; Hertel B; Wyss K; Kirsch T; Woywodt A; Haller H; Haubitz M
Rheumatology (Oxford); 2008 Dec; 47(12):1820-5. PubMed ID: 18927191
[TBL] [Abstract][Full Text] [Related]
29. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
[TBL] [Abstract][Full Text] [Related]
30. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
31. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
Connor DE; Exner T; Ma DD; Joseph JE
Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
[TBL] [Abstract][Full Text] [Related]
32. Microparticles and acute renal dysfunction in septic patients.
Tőkés-Füzesi M; Woth G; Ernyey B; Vermes I; Mühl D; Bogár L; Kovács GL
J Crit Care; 2013 Apr; 28(2):141-7. PubMed ID: 22951018
[TBL] [Abstract][Full Text] [Related]
33. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.
Parker B; Al-Husain A; Pemberton P; Yates AP; Ho P; Gorodkin R; Teh LS; Alexander MY; Bruce IN
Ann Rheum Dis; 2014 Jun; 73(6):1144-50. PubMed ID: 23644670
[TBL] [Abstract][Full Text] [Related]
34. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
Helal O; Defoort C; Robert S; Marin C; Lesavre N; Lopez-Miranda J; Risérus U; Basu S; Lovegrove J; McMonagle J; Roche HM; Dignat-George F; Lairon D
Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):665-71. PubMed ID: 20399083
[TBL] [Abstract][Full Text] [Related]
35. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
36. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
37. Circulating microparticles in neuropsychiatric systemic lupus erythematosus.
Crookston KP; Sibbitt WL; Chandler WL; Qualls CR; Roldan CA
Int J Rheum Dis; 2013 Feb; 16(1):72-80. PubMed ID: 23441775
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
39. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
Elshal M; Abdelaziz A; Abbas A; Mahmoud K; Fathy H; El Mongy S; El-Basyuoni S; Ahmed H; McCoy P
Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
[TBL] [Abstract][Full Text] [Related]
40. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies.
Duval A; Helley D; Capron L; Youinou P; Renaudineau Y; Dubucquoi S; Fischer AM; Hachulla E
Rheumatology (Oxford); 2010 Jun; 49(6):1049-55. PubMed ID: 20211868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
